The previously-recorded webcasts included in this "Events" section are provided as a service to investors and other interested parties. While each of these webcasts was accurate, in all material respects, at the time of the original live webcast, the Company undertakes no obligation whatsoever to update, correct or otherwise modify any of the information contained in these webcasts. Furthermore, to the extent these webcasts contain statements that are not historical, these statements are essentially forward-looking. Forward-looking statements can be identified by their use of words such as "expects," "plans," "will," "may," "anticipates," "believes," "should," "intends," "estimates" and other words of similar meaning. These statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Those statements include statements regarding the intent, belief or current expectations of Columbia and its management team. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements. Such risks and uncertainties include, among other things, the successful marketing of CRINONE® (progesterone gel), PROCHIEVE® 8% (progesterone gel), and PROCHIEVE® 4% (progesterone gel), and STRIANT® (testosterone buccal system); dependence on revenues from significant customers; the impact of competitive products and pricing; the timely and successful development of products; timely and successful completion of clinical studies; success in obtaining acceptance and approval of new products by the FDA and international regulatory agencies; exposure to product liability and other lawsuits; and competitive economic and regulatory factors in the pharmaceutical and healthcare industry; general economic conditions; and other risks and uncertainties that may be detailed, from time-to-time, in Columbia's reports filed with the Securities and Exchange Commission.